Maan Malahfji is a Cardiology physician affiliated with Houston Methodist. OpenAlex indexes 132 publications with 627 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Verona PharmaProgram year202514 paymentsResearch
- Edwards Lifesciences CorporationProgram year20251 payment
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
89%Statin27%Rosuvastatin Calcium61%Atorvastatin Calcium35%Pravastatin Sodium4%Part D<11 patientsBeta blocker18.8%Metoprolol Succinate55%Carvedilol27%Metoprolol Tartrate11%Bisoprolol Fumarate7%Part D<11 patients+ 14 more classes in this area
Blood & clotting
9.2%Factor Xa inhibitor8.1%Eliquis81%Xarelto19%Part D<11 patientsP2Y12 inhibitor1.1%Clopidogrel100%Part D<11 patientsMetabolism & gastrointestinal
1.7%SGLT2 inhibitor1.7%Farxiga100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Pericarditis in Patients with Autoimmune Disease: Insights into Prevalence and Optimal Management
Methodist DeBakey Cardiovascular Journal
2026 - Impact of Concomitant Mitral Regurgitation in Moderate Aortic Stenosis
JACC. Cardiovascular imaging
2026 - Machine Learning Identification of Patient Phenoclusters in Aortic Regurgitation
JACC. Cardiovascular imaging
2025 - Staging of Cardiac Adverse Remodeling in Moderate or Severe Aortic Regurgitation
JACC. Cardiovascular imaging
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Neal Kleiman, MD
Houston Methodist
William Zoghbi, MD
Houston Methodist
Eleftherios Mylonakis, MD
Houston Methodist
Dipan Shah, MD
Houston Methodist
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Martin Leon, MD
Columbia University Irving Medical Center
Scott Solomon, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”